Sustained virological response to interferon- plus ribavirin decreases inflammation and endothelial dysfunction markers in HIV/HCV co-infected patients | Zendy

María G. Guzmán | Zendy; Juan Berenguer | Zendy; Isabel Fernández de Castro | Zendy; Dariela Micheloud | Zendy; J. C. Lopez | Zendy; Jaime Cosín | Zendy; Pilar Miralles | Zendy; Raquel Lorente | Zendy; Teresa AldámizEchevarría | Zendy; María Ángeles MuñozFernández | Zendy; Salvador Resino | Zendy

Open Access

Sustained virological response to interferon- plus ribavirin decreases inflammation and endothelial dysfunction markers in HIV/HCV co-infected patients

Author(s) -

María G. Guzmán,

Juan Berenguer,

Isabel Fernández de Castro,

Dariela Micheloud,

J. C. Lopez,

Jaime Cosín,

Pilar Miralles,

Raquel Lorente,

Teresa AldámizEchevarría,

María Ángeles MuñozFernández,

Salvador Resino

Publication year - 2011

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkq518

Subject(s) - medicine , ribavirin , immunology , viral load , e selectin , endothelial dysfunction , hepatitis c virus , inflammation , interferon , endothelial activation , gastroenterology , cell adhesion , virus , biology , cell , genetics

Hepatitis C virus (HCV) antiviral therapy might lead to decreased chronic immune activation and endothelial dysfunction associated with cardiovascular risk. The aim was to evaluate the effect of HCV eradication on serum markers of inflammation and endothelial dysfunction markers in HIV/HCV co-infected patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research